Brian C. Stephenson, See Remarks at BridgeBio Pharma, Inc. (BBIO), sold 10,800 shares at $31.68 ($334K) on 2020-07-01, disclosed to the SEC on 2020-07-06.
Open-market sale of $334k BBIO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.64 | 7,900 | $242K | 72.5% |
| 2 | $31.68 | 2,800 | $89K | 26.6% |
| 3 | $32.49 | 100 | $3K | 1.0% |
| Total | $30.93 avg | 10,800 | $334K | 100% |
| Filing → |
| FTH | BUY | 2026-06-24 | $406K | — | Filing → |
| BBIO | SELL | 2025-02-27 | $282K | — | Filing → |
| BBIO | SELL | 2025-02-19 | $300K | — | Filing → |